Compare Global Payments Inc (GPN) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global Payments Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Global Payments Inc trades at $85.46 (market cap $22.72B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.6× Global Payments Inc's market cap, and Global Payments Inc pays the higher dividend (1.16%). Which is the better fit depends on your goals.
| GPN | REGN | |
|---|---|---|
Market Cap | $22.72B | $82.06B |
Sector | Industrials | Health |
52-Week High | $90.01 | $812.27 |
52-Week Low | $62.47 | $555.51 |
Enterprise Value | $40.87B | $76.77B |
Dividend Yield | 1.16% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global Payments Inc
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.
Read more on GPN →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
